135 related articles for article (PubMed ID: 34667114)
1. DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy.
Bildik G; Liang X; Sutton MN; Bast RC; Lu Z
Mol Cancer Ther; 2022 Jan; 21(1):25-37. PubMed ID: 34667114
[TBL] [Abstract][Full Text] [Related]
2. RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells.
Sutton MN; Yang H; Huang GY; Fu C; Pontikos M; Wang Y; Mao W; Pang L; Yang M; Liu J; Parker-Thornburg J; Lu Z; Bast RC
Autophagy; 2018; 14(4):637-653. PubMed ID: 29368982
[TBL] [Abstract][Full Text] [Related]
3. DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1.
Sutton MN; Huang GY; Liang X; Sharma R; Reger AS; Mao W; Pang L; Rask PJ; Lee K; Gray JP; Hurwitz AM; Palzkill T; Millward SW; Kim C; Lu Z; Bast RC
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31003488
[TBL] [Abstract][Full Text] [Related]
4. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
Mao W; Peters HL; Sutton MN; Orozco AF; Pang L; Yang H; Lu Z; Bast RC
Cancer; 2019 Apr; 125(8):1267-1280. PubMed ID: 30620384
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers.
Yu Y; Luo R; Lu Z; Wei Feng W; Badgwell D; Issa JP; Rosen DG; Liu J; Bast RC
Methods Enzymol; 2006; 407():455-68. PubMed ID: 16757345
[TBL] [Abstract][Full Text] [Related]
6. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7.
Lu Z; Yang H; Sutton MN; Yang M; Clarke CH; Liao WS; Bast RC
Cell Death Differ; 2014 Aug; 21(8):1275-89. PubMed ID: 24769729
[TBL] [Abstract][Full Text] [Related]
7. DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells.
Lu Z; Baquero MT; Yang H; Yang M; Reger AS; Kim C; Levine DA; Clarke CH; Liao WS; Bast RC
Autophagy; 2014 Jun; 10(6):1071-92. PubMed ID: 24879154
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
Lu Z; Luo RZ; Lu Y; Zhang X; Yu Q; Khare S; Kondo S; Kondo Y; Yu Y; Mills GB; Liao WS; Bast RC
J Clin Invest; 2008 Dec; 118(12):3917-29. PubMed ID: 19033662
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor DiRas3 forms a complex with H-Ras and C-RAF proteins and regulates localization, dimerization, and kinase activity of C-RAF.
Baljuls A; Beck M; Oenel A; Robubi A; Kroschewski R; Hekman M; Rudel T; Rapp UR
J Biol Chem; 2012 Jun; 287(27):23128-40. PubMed ID: 22605333
[TBL] [Abstract][Full Text] [Related]
10. Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
Blessing AM; Santiago-O'Farrill JM; Mao W; Pang L; Ning J; Pak D; Bollu LR; Rask P; Iles L; Yang H; Tran S; Elmir E; Bartholomeusz G; Langley R; Lu Z; Bast RC
Cancer; 2020 Aug; 126(15):3579-3592. PubMed ID: 32484926
[TBL] [Abstract][Full Text] [Related]
11. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters.
Sutton MN; Lu Z; Li YC; Zhou Y; Huang T; Reger AS; Hurwitz AM; Palzkill T; Logsdon C; Liang X; Gray JW; Nan X; Hancock J; Wahl GM; Bast RC
Cell Rep; 2019 Dec; 29(11):3448-3459.e6. PubMed ID: 31825828
[TBL] [Abstract][Full Text] [Related]
12. Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression.
Sutton MN; Huang GY; Zhou J; Mao W; Langley R; Lu Z; Bast RC
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31052266
[TBL] [Abstract][Full Text] [Related]
13. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
Badgwell DB; Lu Z; Le K; Gao F; Yang M; Suh GK; Bao JJ; Das P; Andreeff M; Chen W; Yu Y; Ahmed AA; S-L Liao W; Bast RC
Oncogene; 2012 Jan; 31(1):68-79. PubMed ID: 21643014
[TBL] [Abstract][Full Text] [Related]
14. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
15. Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice.
Qiu J; Li X; He Y; Sun D; Li W; Xin Y
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1869-1886. PubMed ID: 30043279
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.
Lu Z; Bast RC
Cell Adh Migr; 2013; 7(2):232-6. PubMed ID: 23357870
[TBL] [Abstract][Full Text] [Related]
17. Membrane anchoring of the DIRAS3 N-terminal extension permits tumor suppressor function.
Liang X; Jung SY; Fong LW; Bildik G; Gray JP; Mao W; Zhang S; Millward SW; Gorfe AA; Zhou Y; Lu Z; Bast RC
iScience; 2023 Nov; 26(11):108151. PubMed ID: 37915607
[No Abstract] [Full Text] [Related]
18. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
[TBL] [Abstract][Full Text] [Related]
19. GTP-binding protein Di-RAS3 diminishes the migration and invasion of non-small cell lung cancer by inhibiting the RAS/extracellular-regulated kinase pathway.
Kuang P; Xie A; Deng J; Tang J; Wang P; Yu F
Bioengineered; 2022 Mar; 13(3):5663-5674. PubMed ID: 35170376
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic DIRAS3 promotes malignant phenotypes of glioma by activating EGFR-AKT signaling.
Peng Y; Jia J; Jiang Z; Huang D; Jiang Y; Li Y
Biochem Biophys Res Commun; 2018 Oct; 505(2):413-418. PubMed ID: 30266404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
